A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
A phase 3 trial of Fulzerasib, Garsorasib and Glecirasib in Non-small-cell lung cancer, run by Shandong Suncadia Medicine Co., Ltd., not yet recruiting.
Overview
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment is a phase 3 interventional study registered as NCT07601048 by Shandong Suncadia Medicine Co., Ltd., with 450 participants planned, started 2026-06 and due to reach its primary completion in 2028-05. Interventions recorded: HRS-7058, Fulzerasib Tablets, Garsorasib Tablets, Glecirasib Citrate Tablets. Conditions recorded: KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment.
Linked to the drug Fulzerasib because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
Shares Jiangsu Hengrui Pharmaceuticals, Non-small-cell lung cancer and the tag pipeline.
- TrialNeoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
Shares Fulzerasib and the tag pipeline.
- TrialA Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation
Shares Fulzerasib and the tag pipeline.
- TrialA Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China
Shares Glecirasib, Non-small-cell lung cancer and the tag pipeline.
- TrialStudy to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
Shares Garsorasib and the tag pipeline.
- TrialA TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Shares Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialHetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
Shares Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals and the tag pipeline.